Flonase, Zaditor DTC Ads Cited By FDA; Both Allergy Campaigns Are Over
Executive Summary
FDA is directing GlaxoSmithKline and Novartis to revise direct-to-consumer ads for allergy products attempting to capitalize on the changes in the market following the OTC switch of Claritin
You may also be interested in...
FDA Invites Manufacturers, Ad Agencies To Discuss DTC Ad Designs
FDA would like to consult with pharmaceutical companies and their advertising agencies early on in the development of direct-to-consumer advertising campaigns
FDA Invites Manufacturers, Ad Agencies To Discuss DTC Ad Designs
FDA would like to consult with pharmaceutical companies and their advertising agencies early on in the development of direct-to-consumer advertising campaigns
DTC Comparative Drug Campaigns To Be Addressed At FDA Public Meeting
Standards for comparative drug claims in direct-to-consumer ads will be one topic for discussion during a Sept. 22-23 FDA public meeting on consumer-directed promotion of prescription drugs